Masashi Hirota
Impact in
- Hepatology top 5%
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Gastroenterology top 10%
Papers in
- Surgery 28
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
-
- Gastric Cancer Management and Outcomes 10
- Gallbladder and Bile Duct Disorders 6
- Co-authors
- Akimasa Nakao (11 shared papers)Hiroyuki Sugimoto (11 shared papers)Tetsuya Kaneko (8 shared papers)Shin Takeda (9 shared papers)Yuichiro� Doki (15 shared papers)Masaki Mori (10 shared papers)Soichiro Inoue (6 shared papers)Ekmel Tezel (1 shared paper)
- Journals
- Liver International (3 papers)Endoscopy (3 papers)Surgical Endoscopy (2 papers)Esophagus (2 papers)Surgery Today (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Masashi Hirota
70 papers receiving 554 citations
Peers
Comparison fields: 5 of 62
- Hepatology 129
- Gastroenterology 31
- Pulmonary and Respiratory Medicine 161
- Surgery 198
- Oncology 103
Countries citing papers authored by Masashi Hirota
This map shows the geographic impact of Masashi Hirota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Hirota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Hirota more than expected).
Fields of papers citing papers by Masashi Hirota
This network shows the impact of papers produced by Masashi Hirota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Hirota. The network helps show where Masashi Hirota may publish in the future.
Co-authors
The 25 scholars most cited alongside Masashi Hirota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 57 | |
| 2 | 2017 | 38 | |
| 3 | 2006 | 33 | |
| 4 | 2006 | 30 | |
| 5 | 2005 | 29 | |
| 6 | 2013 | 22 | |
| 7 | 2009 | 20 | |
| 8 | 2005 | 18 | |
| 9 | 2018 | 18 | |
| 10 | 2014 | 18 | |
| 11 | 2015 | 16 | |
| 12 | 2014 | 16 | |
| 13 | 2005 | 14 | |
| 14 | 2009 | 14 | |
| 15 | 2005 | 14 | |
| 16 | 2018 | 12 | |
| 17 | 2004 | 12 | |
| 18 | [A long survival case of unresectable pancreatic cancer by chemoradiotherapy with gemcitabine as key drug]. | 2008 | 12 |
| 19 | 2017 | 11 | |
| 20 | 2016 | 10 |
About Masashi Hirota
Masashi Hirota is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Hepatology, having authored 78 papers that have together received 569 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Gastric Cancer Management and Outcomes (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Neuroendocrine Tumor Research Advances (7 papers), Gastrointestinal Tumor Research and Treatment (6 papers), Gallbladder and Bile Duct Disorders (6 papers), Liver Disease and Transplantation (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Hepatology (129 citations), Gastroenterology (31 citations), Pulmonary and Respiratory Medicine (161 citations), Surgery (198 citations) and Oncology (103 citations). Masashi Hirota has collaborated with scholars based in Japan and United States. Frequent co-authors include Akimasa Nakao, Hiroyuki Sugimoto, Tetsuya Kaneko, Shin Takeda, Yuichiro� Doki, Masaki Mori, Soichiro Inoue, Ekmel Tezel, Kiyokazu Nakajima and Makoto Yamasaki. Their work appears in journals such as Liver International, Endoscopy, Surgical Endoscopy, Esophagus and Surgery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.